Zdrowie i gospodarka · 21/05/2021

FDA Releases Draft Guidance on Adjusting for Covariates in Clinical Trials for Drugs and Biological Products

The Food and Drug Administration (FDA) has published a draft guidance outlining its recommendations for adjusting for covariates in randomized clinical trials for drugs and biologics, which is expected to be finalized and replace its previous 2019 guidance